Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 32,800 shares at $100.72 ($3.3M) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Open-market sale of $3.3M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.94 | 7,458 | $738K | 22.7% |
| 2 | $98.94 | 7,458 | $738K | 22.7% |
| 3 | $99.47 | 8,342 | $830K | 25.5% |
| 4 | $99.47 | 8,342 | $830K | 25.5% |
| 5 | $100.72 | 1,200 | $121K | 3.7% |
| Total | $99.27 avg | 32,800 |
| $3.3M |
| 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |